Prevalence of Echocardioghraphic and ECG Changes in Patients With Acute Pancreatitis and Its Impact on Outcome.
1 other identifier
observational
30
0 countries
N/A
Brief Summary
Cardiovascular system involvement with acute pancreatitis has been described before in the form of ECG changes and echocardiographic findings. However the correlation between these changes and the outcome of acute pancreatitis has not been and whether they can be used to predict mortality in these patients has been controversial.In the current study our aim is to detect echocardioghraphic and ECG changes in acute pancreatitis and investigate the significance of these changes on prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2019
CompletedFirst Posted
Study publicly available on registry
December 12, 2019
CompletedStudy Start
First participant enrolled
December 31, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedDecember 12, 2019
December 1, 2019
2 years
October 12, 2019
December 10, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Echocardiographic (mainly diastolic dysfunction & pericardial effusion) and ECG changes (mainly QT interval) in patients with acute pancreatitis.
To detect the echocardiographic (mainly diastolic dysfunction \& pericardial effusion) and ECG changes (mainly QT interval) in patients with acute pancreatitis.
at admission on 1st day
determine the impact of these changes on outcome of patients
determine the impact of these changes on outcome of patients
though out hospital admission (an average of 1 week)
Interventions
transthoracic echocariography, 12 lead ECG
Eligibility Criteria
all patients with acute pancreatitis aged more than 18 yrs \& less than 80 years old not known cardiac and with no pre-existing diabetes, chronic renal failure or malignancy with no hx of chronic pancreatitis admitted to Al-raghy ICU of all etiologies
You may qualify if:
- all patients with acute pancreatitis aged more than 18 yrs admitted to Al-raghy ICU of all etiologies
You may not qualify if:
- patients less that 18 years
- patients above 80 years
- patients with known cardiac disease
- patients with pre-existing diabetes, chronic renal failure or malignancy.
- patients with underlying chronic pancreatitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mahmoud Ashry, professor
Assiut University
- STUDY DIRECTOR
Lobna Abdelwahid, assistant professor
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 12, 2019
First Posted
December 12, 2019
Study Start
December 31, 2019
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
December 12, 2019
Record last verified: 2019-12